FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...
BD has expanded a Class I Alaris recall to cover 15 additional pump infusion sets, the company said Friday. The Food and Drug Administration posted the company's notice on Monday. The company added ...
A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
WASHINGTON (dpa-AFX) - Becton, Dickinson and Co. or BD (BDX) on Thursday provided an update on two voluntary recalls related to certain Alaris Pump Modules Model 8100 manufactured between April 2011 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
For BD, bad things seem to come in eights: The medtech giant issued a cybersecurity bulletin Thursday describing an octad of potential hacking risks it has discovered within certain versions of its ...
Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results